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Identifying MicroRNA and Gene Expression Networks
Using Graph Communities
Benika Hall, Andrew Quitadamo, and Xinghua Shi
Abstract: Integrative network analysis is powerful in helping understand the underlying mechanisms of genetic and
epigenetic perturbations for disease studies. Although it becomes clear that microRNAs, one type of epigenetic
factors, have direct effect on target genes, it is unclear how microRNAs perturb downstream genetic neighborhood.
Hence, we propose a network community approach to integrate microRNA and gene expression profiles, to
construct an integrative genetic network perturbed by microRNAs. We apply this approach to an ovarian cancer
dataset from The Cancer Genome Atlas project to identify the fluctuation of microRNA expression and its effects on
gene expression. First, we perform expression quantitative loci analysis between microRNA and gene expression
profiles via both a classical regression framework and a sparse learning model. Then, we apply the spin glass
community detection algorithm to find genetic neighborhoods of the microRNAs and their associated genes. Finally,
we construct an integrated network between microRNA and gene expression based on their community structure.
Various disease related microRNAs and genes, particularly related to ovarian cancer, are identified in this network.
Such an integrative network allows us to investigate the genetic neighborhood affected by microRNA expression
that may lead to disease manifestation and progression.
Key words: network integration; graph community detection; spin glass algorithm; microRNA networks

1

Introduction

Integrating various types of biological data has
been increasingly powerful for analyzing biological
systems. Particularly, integrative methods provide a
useful outlook into understanding how epigenetic
factors, including microRNAs (miRNAs), affect human
health and disease. Recently, the functional influence
of miRNAs on gene expression has become an
important part of disease studies. Previous studies have
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shown that Single Nucleotide Polymorphisms (SNPs)
affect miRNA expression[1–3] through the technique of
expression Quantitative Trait Loci (eQTL) mapping[4] .
These miRNA eQTL studies integrated SNP genotype
data with miRNA expression by finding significant
associations among SNPs and miRNA expression.
Recent studies demonstrate that integrating multidimensional data provides invaluable findings in
various traits and diseases[5, 6] . While there has been
much success with the current eQTL mapping methods,
there are some critical factors hinder our understanding
of how these loci contribute to diseases at a system
level. For instance, these studies integrate only two
layers of data that are available, assuming that
individual SNPs and miRNAs are independent on each
other. Since genes do not act in isolation, we should
investigate downstream effects caused by eQTLs and
then perturbed genes. miRNAs have been shown before
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that they fine tune gene expression through posttranscriptional processes, albeit a lack of systematic
analysis. With the availability of multiple layers of
data, we should design methods to integrate these data
together for a more systematic view of how miRNAs
perturb gene expression.
In this paper, we integrate data from various sources
such as miRNA expression profiles, gene expression
quantifications, miRNA targets, and protein-protein
interactions. Using these data sources, we propose
a network integration approach to expand eQTL
associations based on interactome networks. We believe
that by extending an eQTL network we can observe
direct and indirect downstream effects of eQTLs.
Particularly, we applied our approach to study how
miRNAs affect gene expression and their downstream
genes in their neighborhood in ovarian cancer. Our
results show that our extended miRNA eQTL network
covers miRNAs and genes related to disease or cancers,
such as ovarian cancer.
Although focused on integrating miRNA and
gene expression in this paper, our approach is
applicable to study the genetic neighborhood
perturbed by other factors like genetic variants.
The code for our approach is freely accessible from
https://github.com/shilab/community-detection/.

2

Methods

As shown in Fig. 1, our approach is composed of six
steps as follows: (1) Data Collection: We collected
and pre-processed miRNA/gene expression data and
interactions. (2) eQTL Analysis: We performed an
eQTL analysis between miRNA and gene expression

Fig. 1

The overall workflow of our approach.
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profiles using two complementary methods, Matrix
eQTL[7] and MTLasso2[8] . (3) Network Integration:
We merged the eQTL associations, miRNA targets,
and protein-protein interaction networks into a baseline
network that captures the relationship among miRNAs
and genes, much like our previous work[9] . Specifically,
we performed database searches to identify direct
miRNA targets. We then overlapped those results with
a protein-protein interaction network. (4) Community
Detection: We performed community detection on the
merged network in order to identify communities within
an effective propagation distance from our miRNA
eQTL genes. (5) Statistical Significance: We used the
Wilcoxon-Rank Sum test to determine the statistical
significance of each community in the network. (6)
Network Visualization: Significant communities were
visualized in Cytoscape[10] .
2.1

Analysis of miRNA eQTL associations

The Cancer Genome Atlas (TCGA)[11] data set provides
rich data across different layers for many cancer types.
With an aim of constructing an integrative network
of miRNA and gene expression in ovarian cancer, we
used TCGA data including miRNA expression profiles,
gene expression quantifications, miRNA interaction
networks, and protein-protein networks. In total we
integrated 964 miRNAs and gene targets, and 349 663
interactions from a protein-protein network. We
combined these data to construct a network which
extends from miRNA eQTL perturbations on particular
genes in the TCGA data set. Our goal in this study is to
integrate large-scale data in order to exploit the indirect
effects of miRNA expression on gene expression in
interaction networks in ovarian cancer.
Prior to data integration, we performed an eQTL
analysis between the miRNA expression and gene
expression profiles. The eQTL analysis was performed
using Matrix eQTL[7] , an R package that uses matrix
operations to perform eQTL mapping based on the
assumption that miRNAs and genes are independent
respectively. After quantile normalization of miRNA
and gene expression data respectively, we performed cis
eQTL analysis, whereby we only tested miRNAs which
were within 1 Mb of a gene. To identify associations
between the miRNA and genes, we used a linear
regression model provided by Matrix eQTL. We used
multi-test correction based on False Discovery Rate
(FDR) and chose the significant eQTLs with an FDR
cutoff at <0.01 for further analysis.
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To capture the relationships among miRNA and
gene expression, in addition to Matrix eQTL,
we used an orthologous approach, namely twograph guided multitask Lasso model (MtLasso2G)[8] .
MtLasso2G performs eQTL analysis with consideration
of correlations among miRNAs and genes. MtLasso2G
uses a sparse learning model that incorporates the
relationships among miRNAs and genes respectively.
We used a correlation expression network among
miRNAs, and another co-expressed network among
genes that potentially captured the structure of coregulation networks. MtLasso2G accomplishes eQTL
analysis by adding two regularization terms based on
the two graphs on features (i.e., miRNA expression)
and labels (i.e., gene expression), which are encoded as
miRNA co-expression network and gene co-expression
network in our analysis respectively.
We then merged the eQTLs identified from these
two orthologous approaches and used the miRNA
target genes identified from mirDB[12] to extend the
eQTL network. The merged miRNA eQTL genes were
considered as directly effected genes by miRNAs, and
were used as seed genes to expand the network for an
indirect effect analysis. We then used a human protein
interaction network, namely InWeb[13] , that combines
protein interaction networks from various resources
and across diverse organisms. We first overlapped the
matching genes from our miRNA eQTL analysis with
the InWeb network. Then we kept InWeb interactions
with an edge weight greater than or equal to 0.10.
2.2

Network integration

The initial network was created from the miRNAs
and eQTL associations. Using the miRNAs from
eQTL analysis, we gathered known targets of these
miRNAs to add to our network. With the known targets
and eQTL associations, we overlapped this network
with protein-protein interactions collected from the
InWeb network[13] . We overlapped these two resulted
networks by common genes shared in the networks,
and generated a merged edge list to represent our
integrated network. This allowed us to link the miRNAs
to downstream targets by genes they share in common
initially.
After generating this extended network, we
performed community detection to identify downstream
genes that interact directly with target genes affected
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by miRNAs. In particular, we used the spin glass
community detection algorithm from igraph[14] , which
is primarily based on thermodynamics[15–17] . The
semi-supervised spin glass algorithm is coupled
with simulated annealing and is less computationally
intensive compared to other methods based on
optimizing the modularity of a network. The
computational efficiency makes it attractive for
large-scale networks. The communities provide a
scope of interactions directly affected by genotypic
perturbations on the miRNA level.
Using the spin model, the problem of community
detection is mapped as identifying the spin states, which
are the community indexes. The model is based on
optimizing the qualifying energy function, known as
the Hamiltonian, in Eq. (1) such that it minimizes the
energy and maximizes the modularity of the system.
H. / D Ai;j pi;j ı.i ; j /

(1)

Here, Ai;j is the adjacency matrix consisting of nodes
i and j and the edges between them;
represents
the weights and i and j represent the spin states
or community indices which nodes i and j belong to
in the network. In this function, pi;j represents the
probability of an edge between nodes i and j . Thus, the
adjacency matrix represents the relationships between
nodes and edges based on the weights determined by
. In reference to , i and j represent each community
index. The Kronecker delta function has a binary value
of 1 if the nodes represented by i and j are in the
same community, otherwise it is 0. This function is
optimized throughout the community detection process.
An advantage of this algorithm is that it can detect
overlapping communities without the network being
affected by the degeneracy of the Hamiltonian.
Once the community detection process was
completed, we selected those detected communities
with nodes overlapping with miRNA associated
genes from eQTL analysis. We used the network
communities constructed here to expand the miRNAgene associations by including genetic neighborhood
encoded as protein-protein interactions from the InWeb
network. Nevertheless, the community detection
algorithm can be used on any genetic network as
a guide. For example, we can perform community
detection on a genetic regulatory network and find
communities extended from miRNA associated genes.
In this study, we selected the direct and indirect

Benika Hall et al.: Identifying MicroRNA and Gene Expression Networks Using Graph Communities

genes within an effective propagation distance[18] of
the miRNAs in the ovarian cancer data set, generally
at most six nodes. Nodes further from the source
may not receive the perturbation signal, thus not being
affected. Focusing on targets within close proximity,
we chose to only visualize those genes that are within
two neighbors away. The downstream effect can include
downstream genes further than two neighbors, creating
a larger community of downstream targets.
For selected communities, we used the Wilcoxon
Rank-Sum test to determine the statistical significance.
The Wilcoxon Rank-Sum tests the significance of the
internal and external degrees of the vertices in the graph.
This allowed us to measure the significance of the
community relative to the graph. Then we visualized
in Cytoscape[10] for further analysis.

3
3.1

Results and Discussion
Integrated network

We constructed an extended network consisting of
miRNA eQTL genes as seed nodes, immediate target
genes from the miRNA eQTL mapping results, and
the indirect genes from the communities in the
protein-protein interaction network. The edges of
the constructed network include the miRNA eQTL
associations between miRNAs and their affected genes
and the interactions among miRNA directly affected
genes and their downstream genes in a neighborhood.
The final integrated network consisted of miRNAs,
their associated genes, protein-protein interactions,
and targets from miRNA associated genes. The spin
glass algorithm detected 25 communities. Of these 25
communities, we were only interested in communities
that were linked to our miRNAs and associated genes,
thus giving us 12 communities to further analyze.
We used the Wilcoxon Rank-Sum test to determine
the statistical significance. We found that all genetic
communities affected miRNAs had considerably low
p-values, thus being statistically significant in our
network. This leads us to believe that the miRNAs
significantly impact gene expression in the extended
network. We can analyze the communities further to
understand their impact in a biological system.
The integrated network is essentially composed
of genes that are directly or indirectly affected by
miRNA expression in ovarian cancer using TCGA
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datasets. Using the miRNA associated genes as seed
genes, we extended the miRNA-gene associations
through the communities detected from the spin glass
algorithm. For our network analysis, we viewed specific
communities from the InWeb network that were linked
to these miRNAs and their downstream genes within
an effective propagation distance (e.g., within two
neighbors of miRNA associated genes). By including
these neighbor genes, we captured both direct genes
and indirect genes in a genetic neighborhood that were
affected by miRNA expression. As an example of our
extended network, please view Fig. 2.
3.2

Disease associations

In efforts to understand any disease associations in our
network, we queried the miRNA associated genes in the
Online Mendelian Inheritance in Man (OMIM) Disease
database[19] . We found 59 genes were associated
with diseases in OMIM. For example, NUMA1 is a
nuclear mitotic asparatus protein found to be overexpressed in epithelial ovarian cancer, contributing
to chromosomal instability[20] . Our integrated network
shows that NUMA1 is indirectly linked to mir15b. Please see Table 1 for other disease genes in our
results. A visualization of the community containing
known miRNAs can be seen in Fig. 3. Shown in this
figure is mir-200c and its immediate targets within an
effective propagation distance. mir-200c is a prognostic
marker in ovarian cancer and is often associated with
metastasis in other cancers. More examples of the
miRNAs are shown in Table 2.

4

Conclusion

In this study, we developed a method based on
community detection to construct an integrative view of
the miRNA and gene expression network. Specifically,
We used miRNA expression, gene expression, miRNA
targets, and protein-protein interactions. We integrated
this data to create a community-based network affected
by miRNA perturbations. Hence, our resulted miRNA
gene expression network includes the direct and indirect
genetic neighborhood that are affected by miRNAs and
their target genes.
In the future, we will include other types of
biological networks such as regulatory networks to
capture other types of relationships among genes. Our
method is also applicable to build other biological
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Fig. 2 An example of a community in the miRNA interaction network that contained miRNAs, their associated genes,
and downstream genes that are indirectly affected by the miRNAs. The miRNAs are denoted by purple triangles and
their immediate targets are represented by dashed blue lines while the indirect targets are shown as a solid gray line. All
downstream targets from OMIM database are green nodes. Yellow nodes have yet to be directly associated with a disease of
phenotype.
Table 1

A summary table showing the genes affected by eQTLs that are OMIM disease genes.

Gene
CDKN1C, KIP2, BWS, IMAGE
CDKN1C, KIP2, BWS, IMAGE
DGCR2, DGS2

Description
Cyclin-dependent kinase inhibitor 1C (p57, Kip2)
Cyclin-dependent kinase inhibitor 1C (p57, Kip2)
The DiGeorge syndrome chromosome region-2

HNRNPA1, IBMPFD3, ALS20

Heterogeneous nuclear ribonucleoprotein A1

HNRNPA1, IBMPFD3, ALS20
KIAA1279
KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9
KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9
KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9
LDLRAP1, ARH, FHCB2, FHCB1
NUMA1
POMC
POMC
RECQL4, RTS, RECQ4
RECQL4, RTS, RECQ4
RECQL4, RTS, RECQ4
SLC25A3, PHC
TUBB, TUBB5, M40, CDCBM6

Heterogeneous nuclear ribonucleoprotein A1
KIAA1279 gene
Kinesin family member 1A
Kinesin family member 1A
Kinesin family member 1A
Low density lipoprotein receptor adaptor protein 1
Nuclear mitotic apparatus protein-1
Proopiomelanocortin (adrenocorticotropin/beta-lipotropin)
Proopiomelanocortin (adrenocortic’otropin/beta-lipotropin)
DNA helicase, RecQ-like 4
DNA helicase, RecQ-like 4
DNA helicase, RecQ-like 4
Solute carrier family 25 (mitochondrial carrier), member 3
Tubulin, beta polypeptide

Disease/Phenotype
IMAGE syndrome
Beckwith-Wiedemann syndrome
DiGeorge syndrome/velocardiofacial syndrome complex-2
Inclusion body myopathy wtih early-onset Paget disease
without frontotemporal dementia 3
Amyotrophic lateral sclerosis 20
Goldberg-Shprintzen megacolon syndrome
Spastic paraplegia 30, autosomal recessive
Neuropathy, hereditary sensory, type IIC
Mental retardation, autosomal dominant 9
Hypercholesterolemia, familial, autosomal recessive
Leukemia, acute promyelocytic, NUMA/RARA type
Obesity, adrenal insufficiency, and red hair due to POMC deficiency
Obesity, early-onset, susceptibility to
Rothmund-Thomson syndrome
RAPADILINO syndrome
Baller-Gerold syndrome
Mitochondrial phosphate carrier deficiency
Cortical dysplasia, complex, with other brain malformations 6
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Fig. 3

Visualization of a community in our extended network with known miRNAs in ovarian cancer.
Table 2

List of miRNAs matched with the mirCancer database.

Cancer

SNP/miRNA

hsa-let-7f-2
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Profile

Breast cancer

Down

Bronchioloalveolar carcinoma

Down

Colon cancer

Down

Esophageal squamous cell carcinoma Down
Hepatocellular carcinoma

Down

Lung cancer

Down

PubMed
Breast cancer-specific TRAIL expression mediated by miRNA
response elements of let-7 and miR-122.
let-7 microRNA expression is reduced in bronchioloalveolar
carcinoma, a non-invasive carcinoma, and is not correlated with
prognosis.
let-7 microRNA functions as a potential growth suppressor in
human colon cancer cells.
Role of microRNA let-7 and effect to HMGA2 in esophageal
squamous cell carcinoma.
MicroRNAs in Hepatobiliary and Pancreatic Cancers.
Reduced expression of Dicer associated with poor prognosis in lung
cancer patients.
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Table 2

Cancer

SNP/miRNA

hsa-let-7f-2

List of miRNAs matched with the mirCancer database.
Profile

Nasopharyngeal carcinoma

Down

Neuroblastoma

Down

Pancreatic ductal adenocarcinoma

Down

Gastric cancer

Up

Glioma

Up

Head and neck squamous cell carcinoma Up
hsa-mir-106b

Hepatocellular carcinoma

Up

Laryngeal carcinoma

Up

Medulloblastoma

Up

hsa-mir-1180 Bladder cancer

Down

Hepatocellular carcinoma

Up

Gastric cancer

Down

Acute myeloid leukemia

Up

Bladder cancer

Down

Breast cancer

Down

Chronic lymphocytic leukemia

Down

Follicular cancer

Up

Gastric cancer

Up

Glioblastoma

Down

Glioma

Up

Hepatocellular carcinoma

Down

Malignant melanoma
Neuroblastoma

Down
Up

Oral squamous cell carcinoma

Down

Osteosarcoma

Down

hsa-mir-1228

hsa-mir-125b

(Continued)

PubMed
MicroRNA let-7 suppresses nasopharyngeal carcinoma cells
proliferation through downregulating c-Myc expression.
LIN28B induces neuroblastoma and enhances MYCN levels via let7 suppression.
let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits
in vitro cell proliferation but fails to alter tumor progression.
Circulating microRNAs in plasma of patients with gastric cancers.
Down-regulation of miR-106b suppresses the growth of human
glioma cells.
Comprehensive MicroRNA profiling for head and neck squamous
cell carcinomas.
Upregulation of microRNA-106b is associated with poor prognosis
in hepatocellular carcinoma.
MiR-106b promotes cell proliferation via targeting RB in laryngeal
carcinoma.
miR-106b is overexpressed in medulloblastomas and interacts
directly
with PTEN.
Up-regulation of p21(WAF1/CIP1) by miRNAs and its implications
in bladder cancer cells.
miR-1228 promotes the proliferation and metastasis of hepatoma
cells through a p53 forward feedback loop.
Restoration of miR-1228* expression suppresses epithelialmesenchymal transition in gastric cancer.
[miR-125b promotes proliferation of human acute myeloid
leukemia cells by targeting Bak1].
MicroRNA-125b suppresses the development of bladder cancer by
targeting E2F3.
miR-125b is methylated and functions as a tumor suppressor by
regulating the ETS1 proto-oncogene in human invasive breast
cancer.
The down-regulation of miR-125b in chronic lymphocytic
leukemias leads to metabolic adaptation of cells to a transformed
state.
MicroRNA expression profiling is a potential diagnostic tool for
thyroid cancer.
MiR-125b promotes cell migration and invasion by targeting
PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor
prognosis.
Myc-associated zinc finger protein (MAZ) is regulated by miR125b and mediates VEGF-induced angiogenesis in glioblastoma.
MiR-125b expression affects the proliferation and apoptosis of
human glioma cells by targeting Bmf.
Histone lysine methyltransferase, SUV39H1, promotes HCC
progression and is negatively regulated by microRNA-125b.
miR-125b induces cellular senescence in malignant melanoma.
MicroRNA-125b is a novel negative regulator of p53.
Decreased expression of miR-125b and miR-100 in oral cancer
cells contributes to malignancy.
miR-125b suppresses the proliferation and migration of
osteosarcoma cells through down-regulation of STAT3.
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Table 2

List of miRNAs matched with the mirCancer database.
Cancer

SNP/miRNA

Profile

Ovarian cancer

Down

Prostate cancer

Up

Acute lymphoblastic leukemia

Up

Acute myeloid leukemia

Up

Glioblastoma

Down

Glioma

Down

Osteosarcoma

Up

Prostate cancer

Down

hsa-mir-125b

hsa-mir-128

hsa-mir-1301 Liver cancer

hsa-mir-149

Up

Breast cancer

Down

Colorectal cancer

Down

Gastric cancer

Down

Glioblastoma

Down

Head and neck squamous cell carcinoma Down

hsa-mir-150

Nasopharyngeal carcinoma

Up

Non-small cell lung cancer

Down

Breast cancer

Up

Chronic lymphocytic leukemia

Up

Chronic myelogenous leukemia

Down

Colorectal cancer

Up

Esophageal squamous cell carcinoma

Down

Gastric cancer

Up

Lung adenocarcinoma

Up

Lung cancer

Up

Mantle cell lymphoma

Down

183
(Continued)

PubMed
Micro-RNAs and ovarian cancer: the state of art and perspectives
of clinical research.
Oncomir miR-125b suppresses p14(ARF) to modulate p53dependent and p53-independent apoptosis in prostate cancer.
Distinctive microRNA signature is associated with the diagnosis
and prognosis of acute leukemia.
Distinctive microRNA signature is associated with the diagnosis
and prognosis of acute leukemia.
PDGF-B-mediated downregulation of miR-21: new insights into
PDGF signaling in glioblastoma.
Targeting of the Bmi-1 oncogene/stem cell renewal factor by
microRNA-128 inhibits glioma proliferation and self-renewal.
MicroRNA-128 promotes proliferation in osteosarcoma cells by
downregulating PTEN.
MicroRNA-128 downregulates Bax and induces apoptosis in
human embryonic kidney cells.
Identification of miRNAs that specifically target tumor suppressive
KLF6-FL rather than oncogenic KLF6-SV1 isoform.
MicroRNA-149 targets GIT1 to suppress integrin signaling and
breast cancer metastasis.
MicroRNA-149 Suppresses Colorectal Cancer Cell Migration and
Invasion by Directly Targeting Forkhead Box Transcription
Factor FOXM1.
MicroRNA-149 inhibits proliferation and cell cycle progression
through the targeting of ZBTB2 in human gastric cancer.
miR-128 and miR-149 enhance the chemosensitivity of
temozolomide by Rap1B-mediated cytoskeletal remodeling
in glioblastoma.
The association between genetic polymorphism and the processing
efficiency of miR-149 affects the prognosis of patients with head
and neck squamous cell carcinoma.
miR-149 promotes epithelial-mesenchymal transition and invasion
in nasopharyngeal carcinoma cells.
miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by
Targeting FOXM1.
miR-150 promotes human breast cancer growth and malignant
behavior by targeting the pro-apoptotic purinergic P2X7
receptor.
Opposite prognostic significance of cellular and serum circulating
microRNA-150 in Chronic Lymphocytic Leukemia patients.
Down-regulation of hsa-miR-10a in chronic myeloid leukemia
CD34+ cells increases USF2-mediated cell growth.
Circulating Exosomal microRNAs as Biomarkers of Colon Cancer.
MiR-150 is associated with poor prognosis in esophageal squamous
cell carcinoma via targeting the EMT inducers ZEB1.
MiR-150 promotes gastric cancer proliferation by negatively
regulating the pro-apoptotic gene EGR2.
Altered miR-143 and miR-150 expressions in peripheral blood
mononuclear cells for diagnosis of non-small cell lung cancer.
miR-150 promotes the proliferation and migration of lung cancer
cells by targeting SRC kinase signalling inhibitor 1.
microRNA expression profile and identification of miR-29 as a
prognostic marker and pathogenetic factor by targeting CDK6
in mantle cell lymphoma.
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Table 2

Cancer

Profile

Pancreatic ductal adenocarcinoma

Down

Colorectal cancer

Up

Pancreatic cancer

Down

Glioma

Down

Hepatocellular carcinoma

Up

Non-small cell lung cancer

Down

Papillary thyroid carcinoma

Up

Prostate cancer

Up

Gastric cancer

Up

Glioma

Down

Hepatocellular carcinoma

Up

Neuroblastoma

Down

Non-small cell lung cancer

Down

Osteosarcoma

Up

Papillary thyroid carcinoma

Up

Prostate cancer

Up

Bladder cancer

Down

Colon cancer

Down

Colorectal cancer

Down

Epithelial ovarian cancer

Down

Gastric cancer

Up

Lung cancer

Down

Pancreatic ductal adenocarcinoma

Up

Choriocarcinoma

Down

Follicular thyroid carcinoma

Down

SNP/miRNA

hsa-mir-150

hsa-mir-181a-1

hsa-mir-181c

hsa-mir-192

List of miRNAs matched with the mirCancer database.

hsa-mir-199b

(Continued)

PubMed
A Decrease in miR-150 Regulates the Malignancy of Pancreatic
Cancer by Targeting c-Myb and MUC4.
MicroRNA expression profiles in human colorectal cancers with
liver metastases.
Upregulation of miR-150* and miR-630 Induces Apoptosis in
Pancreatic Cancer Cells by Targeting IGF-1R.
MicroRNA-181 inhibits glioma cell proliferation by targeting
cyclin B1.
Identification of microRNA-181 by genome-wide screening as a
critical player in EpCAM-positive hepatic cancer stem cells.
MicroRNA-181 functions as a tumor suppressor in non-small cell
lung cancer (NSCLC) by targeting Bcl-2.
Expression of miRNAs in Papillary Thyroid Carcinomas Is
Associated with BRAF Mutation and Clinicopathological
Features in Chinese Patients.
microRNA-181 promotes prostate cancer cell proliferation by
regulating DAX-1 expression.
Upregulation of MicroRNA 181c Expression in Gastric Cancer
Tissues and Plasma.
MicroRNA-181 inhibits glioma cell proliferation by targeting
cyclin B1.
Identification of microRNA-181 by genome-wide screening as a
critical player in EpCAM-positive hepatic cancer stem cells.
MiR-181c modulates the proliferation, migration, and invasion of
neuroblastoma cells by targeting Smad7.
MicroRNA-181 functions as a tumor suppressor in non-small cell
lung cancer (NSCLC) by targeting Bcl-2.
MicroRNA signatures associate with pathogenesis and progression
of osteosarcoma.
Expression of miRNAs in Papillary Thyroid Carcinomas Is
Associated with BRAF Mutation and Clinicopathological
Features in Chinese Patients.
microRNA-181 promotes prostate cancer cell proliferation by
regulating DAX-1 expression.
Expression of microRNAs in the Urine of Patients With Bladder
Cancer.
Prognostic significance of miR-215 in colon cancer.
Association of microRNA expression with microsatellite instability
status in colorectal adenocarcinoma.
Gain-of-function microRNA screens identify miR-193a regulating
proliferation and apoptosis in epithelial ovarian cancer cells.
MicroRNA-192 and -215 are upregulated in human gastric cancer
in vivo and suppress ALCAM expression in vitro.
MicroRNA-192 targeting retinoblastoma 1 inhibits cell
proliferation and induces cell apoptosis in lung cancer cells.
Diagnostic and biological significance of microRNA-192 in
pancreatic ductal adenocarcinoma.
Decreased expression of microRNA-199b increases protein
levels of SET (protein phosphatase 2A inhibitor) in human
choriocarcinoma.
Differential miRNA expression defines migration and reduced
apoptosis in follicular thyroid carcinomas.
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Table 2

List of miRNAs matched with the mirCancer database.

SNP/miRNA Cancer
Hepatocellular carcinoma
hsa-mir-199b
Prostate cancer

hsa-mir-200c

hsa-mir-205

185
(Continued)

Profile
PubMed
Down [MicroRNA profiling in patients with hepatocellular carcinoma].
MiR199b Suppresses Expression of Hypoxia-Inducible Factor 1’
Down
(HIF-1’) in Prostate Cancer Cells.
Expression of microRNAs in the Urine of Patients With Bladder
Bladder cancer
Down
Cancer.
Direct targeting of Sec23a by miR-200s influences cancer cell
Breast cancer
Up
secretome and promotes metastatic colonization.
Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits
Cholangiocarcinoma
Down
cholangiocarcinoma tumourigenesis and metastasis.
miR-200c inhibits invasion and migration in human colon cancer
Colon cancer
Down
cells SW480/620 by targeting ZEB1.
miR-200c inhibits invasion and migration in human colon cancer
Colorectal cancer
Down
cells SW480/620 by targeting ZEB1.
MicroRNA-200c modulates epithelial-to-mesenchymal transition
Colorectal cancer
Up
(EMT) in human colorectal cancer metastasis.
Plasma miR-200c and miR-18a as potential biomarkers for the
Colorectal cancer
Up
detection of colorectal carcinoma.
The interactions between MicroRNA-200c and BRD7 in
Endometrial cancer
Up
endometrial carcinoma.
The downregulation of miR-200c/141 promotes ZEB1/2 expression
Gastric cancer
Down
and gastric cancer progression.
MicroRNA-200c attenuates tumour growth and metastasis of
Head and neck squamous cell carcinoma Down
presumptive head and neck squamous cell carcinoma stem cells.
Expression of microRNAs, miR-21, miR-31, miR-122, miR145, miR-146a, miR-200c, miR-221, miR-222, and miRHepatocellular carcinoma
Down
223 in patients with hepatocellular carcinoma or intrahepatic
cholangiocarcinoma and its progno
miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis
Lung adenocarcinoma
Down
by targeting Flt1/VEGFR1.
miR-200c Inhibits Melanoma Progression and Drug Resistance
Malignant melanoma
Down
throughDown-Regulation of Bmi-1.
Mesenchymal cancer
Down MicroRNA Expression Profiles in Kaposi’s Sarcoma.
High expression of serum miR-21 and tumor miR-200c associated
Non-small cell lung cancer
Up
with poor prognosis in patients with lung cancer.
Differential microRNA expression signatures and cell type-specific
Ovarian cancer
Up
association with Taxol resistance in ovarian cancer cells.
XMD8-92 Inhibits Pancreatic Tumor Xenograft Growth via
Pancreatic ductal adenocarcinoma
Down
DCLK1-Dependent Mechanism.
The quantitative analysis by stem-loop real-time PCR revealed
Rectal cancer
Up
the microRNA-34a, microRNA-155 and microRNA-200c
overexpression in human colorectal cancer.
miRNA profiling for clear cell renal cell carcinoma: biomarker
Renal clear cell carcinoma
Down
discovery and identification of potential controls and
consequences of miRNA dysregulation.
Expression of microRNAs in the Urine of Patients With Bladder
Bladder cancer
Down
Cancer.
Role of microRNAs-29b-2, -155, -197 and -205 as diagnostic
Breast cancer
Up
biomarkers in serum of breast cancer females.
miR-205 Expression Promotes Cell Proliferation and Migration of
Cervical cancer
Up
Human Cervical Cancer Cells.
miRNAs expression profiling to distinguish lung squamous-cell
Cervical squamous cell carcinoma
Up
carcinoma from adenocarcinoma subtypes.
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Table 2

List of miRNAs matched with the mirCancer database.
Cancer

SNP/miRNA

Profile

Endometrial cancer

Up

Esophageal cancer

Up

Gastric cancer

Down

Glioma

Down

Head and neck squamous cell carcinoma Down

hsa-mir-205

hsa-mir-20a

Hepatocellular carcinoma

Down

Kidney cancer

Down

Laryngeal squamous cell carcinoma

Down

Lung cancer

Up

Malignant melanoma

Down

Non-small cell lung cancer

Up

Ovarian cancer

Up

Prostate cancer

Down

Renal cell carcinoma

Down

Squamous carcinoma

Down

Acute myeloid leukemia

Down

B-cell lymphoma

Up

Breast cancer

Up

Cervical cancer

Up

Cholangiocarcinoma

Up

Colorectal cancer
Esophageal squamous cell carcinoma

Up
Up

Gastric cancer

Up

Glioma

Up

Hepatocellular carcinoma

Down

(Continued)

PubMed
miR-205 promotes tumor proliferation and invasion through
targeting ESRRG in endometrial carcinoma.
Alteration of miRNA Expression Correlates with Lifestyle, Social
and Environmental Determinants in Esophageal Carcinoma.
Down-regulation of MicroRNA-205 promotes gastric cancer cell
proliferation.
MicroRNA-205 functions as a tumor suppressor in human
glioblastoma cells by targeting VEGF-A.
Low-level expression of microRNAs let-7d and miR-205 are
prognostic markers of head and neck squamous cell carcinoma.
Hepatitis B virus X protein inhibits tumor suppressor miR-205
through inducing hypermethylation of miR-205 promoter to
enhance carcinogenesis.
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal
cancer.
MicroRNA-205 suppresses proliferation and promotes apoptosis in
laryngeal squamous cell carcinoma.
Evaluation of dynamic change of serum miR-21 and miR-24 in preand post- operative lung carcinoma patients.
Differential expression of microRNAs during melanoma
progression:
miR-200c, miR-205 and miR-211 are
downregulated in melanoma and act as tumour suppressors.
miR-205 promotes the growth, metastasis and chemoresistance of
NSCLC cells by targeting PTEN.
The role of miR-205 in the VEGF-mediated promotion of human
ovarian cancer cell invasion.
Downregulation of miR-205 and miR-31 confers resistance to
chemotherapy-induced apoptosis in prostate cancer cells.
miRNA-205 Is a Candidate Tumor Suppressor that Targets ZEB2
in Renal Cell Carcinoma.
MicroRNA expression profiles of esophageal cancer.
HIF-1’ downregulates miR-17/20a directly targeting p21 and
STAT3: a role in myeloid leukemic cell differentiation.
MicroRNA miR-17-5p is overexpressed in pancreatic cancer,
associated with a poor prognosis, and involved in cancer cell
proliferation and invasion.
MicroRNA expression profiles in human breast cancer cells after
multifraction and single-dose radiation treatment.
miR-20a promotes migration and invasion by regulating TNKS2 in
human cervical cancer cells.
miR-17-92 cluster promotes cholangiocarcinoma growth: evidence
for PTEN as downstream target and IL-6/Stat3 as upstream
activator.
MicroRNA signatures: novel biomarker for colorectal cancer?
TNF-“ is a novel target of miR-19a.
Involvement of miR-20a in Promoting Gastric Cancer Progression
by Targeting Early Growth Response 2 (EGR2).
[Expression of hsa-miR-20a in human glioma tissues and its effect
on the proliferation of human glioma cells in vitro].
Decrease expression of microRNA-20a promotes cancer cell
proliferation and predicts poor survival of hepatocellular
carcinoma.
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Table 2

Cancer

SNP/miRNA

hsa-mir-20a

hsa-mir-20a-5p

List of miRNAs matched with the mirCancer database.
Profile

Lung cancer

Up

Malignant melanoma

Down

Mantle cell lymphoma

Up

Medulloblastoma

Up

Nasopharyngeal cancer

Up

Osteosarcoma

Up

Ovarian cancer

Up

Prostate cancer

Up

Colorectal cancer

Up

Breast cancer

Down

Colon cancer

Down

Colorectal cancer

Down

Esophageal squamous cell carcinoma Down

hsa-mir-22

hsa-mir-223

Gastric cancer

Down

Hepatocellular carcinoma

Down

Lung cancer

Down

Medulloblastoma

Down

Non-small cell lung cancer

Up

Osteosarcoma

Down

T-cell lymphoma

Down

Acute myeloid leukemia

Down

Bladder cancer

Up

Chronic lymphocytic leukemia

Down

187
(Continued)

PubMed
A polycistronic microRNA cluster, miR-17-92, is overexpressed in
human lung cancers and enhances cell proliferation.
Differential regulation of aggressive features in melanoma cells by
members of the miR-17-92 complex.
The miRNA-17-92 cluster mediates chemoresistance and enhances
tumor growth in mantle cell lymphoma via PI3K/AKT pathway
activation.
The miR-17/92 polycistron is up-regulated in sonic hedgehogdriven medulloblastomas and induced by N-myc in sonic
hedgehog-treated cerebellar neural precursors.
Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as
Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
Upregulation of microRNA-17-92 cluster associates with tumor
progression and prognosis in osteosarcoma.
miR-20a promotes proliferation and invasion by targeting APP in
human ovarian cancer cells.
miR-20a promotes Prostate cancer invasion and migration through
targeting ABL2.
Association of microRNA expression with microsatellite instability
status in colorectal adenocarcinoma.
A regulatory loop involving miR-22, Sp1, and c-Myc modulates
CD147 expression in breast cancer invasion and metastasis.
miRNA-22 suppresses colon cancer cell migration and invasion
by inhibiting the expression of T-cell lymphoma invasion and
metastasis 1 and matrix metalloproteinases 2 and 9.
Clinical significance of miR-22 expression in patients with
colorectal cancer.
Increased miRNA-22 expression sensitizes esophageal squamous
cell carcinoma to irradiation.
microRNA-22 acts as a metastasis suppressor by targeting
metadherin in gastric cancer.
microRNA-22, downregulated in hepatocellular carcinoma and
correlated with prognosis, suppresses cell proliferation and
tumourigenicity.
Tumor suppressor miR-22 suppresses lung cancer cell progression
through post-transcriptional regulation of ErbB3.
MiR-22 is Frequently Down-regulated in Medulloblastomas, and
Inhibits Cell Proliferation via the Novel Target PAPST1.
Circulating miR-22, miR-24 and miR-34a as novel predictive
biomarkers to pemetrexed-based chemotherapy in advanced non
small cell lung cancer.
miR-22 inhibits osteosarcoma cell proliferation and migration by
targeting HMGB1 and inhibiting HMGB1-mediated autophagy.
miRNA-22 suppresses colon cancer cell migration and invasion
by inhibiting the expression of T-cell lymphoma invasion and
metastasis 1 and matrix metalloproteinases 2 and 9.
Cell-cycle regulator E2F1 and microRNA-223 comprise an
autoregulatory negative feedback loop in acute myeloid
leukemia.
Micro-RNA profiling in kidney and bladder cancers.
MicroRNA-223 expression is uniformly down-regulated in B
cell lymphoproliferative disorders and is associated with poor
survival in patients with chronic lymphocytic leukemia.
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Table 2

List of miRNAs matched with the mirCancer database.

Cancer

SNP/miRNA

Colorectal cancer
Endometrial cancer

Esophageal adenocarcinoma
Esophageal cancer

Profile

Gastric cancer

Up

Glioblastoma

Up

Hepatocellular carcinoma

Up

Lung cancer

Down

Mantle cell lymphoma

Down

Nasopharyngeal cancer

Down

Splenic marginal zone lymphoma

Down

hsa-mir-223

Bladder cancer
Gastric cancer

hsa-mir-23b

Glioma

Ovarian cancer

Prostate cancer

hsa-mir-26b

PubMed

Overexpression of miR-223 correlates with tumor metastasis and
Up
poor prognosis in patients with colorectal cancer.
MiR-223 suppresses endometrial carcinoma cells proliferation by
Down
targeting IGF-1R.
MicroRNA 223 is Up-regulated in the Multistep Progression of
Up
Barrett’s Esophagus and Modulates Sensitivity to Chemotherapy
by Targeting PARP1.
Down Differential expression of miRNAs in esophageal cancer tissue.

Esophageal squamous cell carcinoma Up

hsa-mir-223-3p Prostate cancer

(Continued)

Up

Clinical significance of serum miR-223, miR-25 and miR-375 in
patients with esophageal squamous cell carcinoma.
MicroRNA profiling of human gastric cancer.
microRNA-223 promotes the growth and invasion of glioblastoma
cells by targeting tumor suppressor PAX6.
Circulating microRNAs, miR-21, miR-122, and miR-223, in
patients with hepatocellular carcinoma or chronic hepatitis.
miR-223 functions as a potent tumor suppressor of the Lewis
lung carcinoma cell line by targeting insulin-like growth factor-1
receptor and cyclin-dependent kinase 2.
MicroRNA-223 expression is uniformlyDown-regulated in B
cell lymphoproliferative disorders and is associated with poor
survival in patients with chronic lymphocytic leukemia.
Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as
Non-Invasive Biomarkers in Nasopharyngeal Carcinoma.
MicroRNA-223 expression is uniformly down-regulated in B
cell lymphoproliferative disorders and is associated with poor
survival in patients with chronic lymphocytic leukemia.
MiR-223-3p targeting SEPT6 promotes the biological behavior of
prostate cancer.

MicroRNA-23b functions as a tumor suppressor by regulating Zeb1
in bladder cancer.
miRNA-223 promotes gastric cancer invasion and metastasis by
Up
targeting tumor suppressor EPB41L3.
miRNA expression profiling in migrating glioblastoma cells:
Down
regulation of cell migration and invasion by miR-23b via
targeting of Pyk2.
MicroRNAs overexpressed in ovarian ALDH1-positive cells are
Up
associated with chemoresistance.
miR-23b represses proto-oncogene Src kinase and functions as
Down
methylation-silenced tumor suppressor with diagnostic and
prognostic significance in prostate cancer.
Down

Bladder cancer

Up

Breast cancer

Down

Colorectal cancer

Down

Glioma

Down

Hepatocellular carcinoma

Down

Micro-RNA profiling in kidney and bladder cancers.
MiRNA-26b inhibits cellular proliferation by targeting CDK8 in
breast cancer.
Association of microRNA expression with microsatellite instability
status in colorectal adenocarcinoma.
Role of microRNA-26b in glioma development and its mediated
regulation on EphA2.
MicroRNA-26b inhibits epithelial-mesenchymal transition in
hepatocellular carcinoma by targeting USP9X.
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Table 2

List of miRNAs matched with the mirCancer database.
Cancer

SNP/miRNA

Profile

Lung cancer

Down

Oral squamous cell carcinoma

Down

Osteosarcoma

Down

Prostate cancer

Down

Breast cancer

Up

Gastric cancer

Down

hsa-mir-26b

hsa-mir-29b-2 Head and neck squamous cell carcinoma Down

hsa-mir-30d

Hepatocellular carcinoma

Down

Mesenchymal cancer

Down

Hepatocellular carcinoma

Up

Lung cancer

Up

Medulloblastoma

Up

Non-small cell lung cancer

Down

Prostate cancer

Down

Renal cell carcinoma

Down

Chronic myelogenous leukemia

Down

Glioma

Up

Prostate cancer

Down

Glioma

Up

Colon cancer

Down

Colorectal cancer

Down

Glioblastoma

Down

Nasopharyngeal carcinoma

Down

hsa-mir-30e

hsa-mir-320a

189
(Continued)

PubMed
MicroRNA-26a/b Regulate DNA Replication Licensing,
Tumorigenesis and Prognosis by Targeting CDC6 in Lung
Cancer.
MicroRNA expression signature of oral squamous cell carcinoma:
functional role of microRNA-26a/b in the modulation of novel
cancer pathways.
miR-26b inhibits proliferation, migration, invasion and apoptosis
induction via the downregulation of 6-phosphofructo-2kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in
osteosarcoma cells.
Myc enforces overexpression of EZH2 in early prostatic neoplasia
via transcriptional and post-transcriptional mechanisms.
microRNA-29 negatively regulates EMT regulator N-myc
interactor in breast cancer.
Effects of microRNA-29 family members on proliferation and
invasion of gastric cancer cell lines.
Tumour-suppressive microRNA-29s inhibit cancer cell migration
and invasion by targeting laminin-integrin signalling in head and
neck squamous cell carcinoma.
Negative feedback of miR-29 family TET1 involves in
hepatocellular cancer.
miR-29 Acts as a Decoy in Sarcomas to Protect the Tumor
Suppressor A20 mRNA from Degradation by HuR.
MicroRNA-30d promotes tumor invasion and metastasis by
targeting Galphai2 in hepatocellular carcinoma.
Evaluation of dynamic change of serum miR-21 and miR-24 in preand post- operative lung carcinoma patients.
Amplification and overexpression ofhsa-miR-30b, Hsa-miR-30d
and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma.
Clinical evaluation of microRNA expression profiling in non small
cell lung cancer.
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and
EMT.
Proliferation inhibition and the underlying molecular mechanisms
of microRNA-30d in renal carcinoma cells.
MiR-30e induces apoptosis and sensitizes K562 cells to imatinib
treatment via regulation of the BCR-ABL protein.
Ionizing radiation-inducible miR-30e promotes glioma cell
invasion through EGFR stabilization by directly targeting CBLB.
miR-30 as a tumor suppressor connects EGF/Src signal to ERG and
EMT.
MicroRNA-30e* promotes human glioma cell invasiveness in an
orthotopic xenotransplantation model by disrupting the NF›B/I›B’ negative feedback loop.
MicroRNA-320a suppresses human colon cancer cell proliferation
by directly targeting “-catenin.
[Corrigendum] microRNA-320a inhibits tumor invasion by
targeting neuropilin 1 and is associated with liver metastasis in
colorectal cancer.
MicroRNA-320a suppresses in GBM patients and modulates
glioma cell functions by targeting IGF-1R.
MicroRNA-320a inhibits cell proliferation, migration and invasion
by targeting BMI-1 in nasopharyngeal carcinoma.
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Table 2

Cancer

SNP/miRNA
hsa-mir-320b

hsa-mir-328

List of miRNAs matched with the mirCancer database.
Profile

Colorectal cancer

Up

Gastric cancer

Down

Glioma

Down

Non-small cell lung cancer

Up

B-cell lymphoma

Down

Bladder cancer

Down

Breast cancer

Down

Cervical carcinoma

Down

Chordoma

Down

Choriocarcinoma

Down

Colon cancer

Down

Colorectal cancer

Down

Endometrial cancer

Down

Gastric cancer

Down

Glioblastoma

Down

Glioma

Down

hsa-mir-34a

Head and neck squamous cell carcinoma Down
Hepatocellular carcinoma

Down

Lung cancer

Down

Malignant melanoma

Down

Neuroblastoma

Down

Non-small cell lung cancer

Down

(Continued)

PubMed
MicroRNA-320b promotes colorectal cancer proliferation and
invasion by competing with its homologous microRNA-320a.
Macrophage-derived reactive oxygen species suppress miR-328
targeting CD44 in cancer cells and promote redox adaptation.
microRNA-328 is a favorable prognostic marker in human
glioma via suppressing invasive and proliferative phenotypes of
malignant cells.
Peripheral Blood miR-328 Expression as a Potential Biomarker for
the Early Diagnosis of NSCLC.
The Epstein-Barr virus (EBV)-induced tumor suppressor
microRNA MiR-34a is growth promoting in EBV-infected
B cells.
MicroRNA-34a functions as an anti-metastatic microRNA and
suppresses angiogenesis in bladder cancer by directly targeting
CD44.
MicroRNA-34a Suppresses Cell Proliferation by Targeting LMTK3
in Human Breast Cancer MCF-7 Cell Line.
MicroRNA-34a suppresses invasion through downregulation of
Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma
cells.
MicroRNA-608 and microRNA-34a regulate chordoma
malignancy by targeting EGFR, Bcl-xL and MET.
MicroRNA-34a suppresses invasion through downregulation of
Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma
cells.
MicroRNA-34a inhibits migration and invasion of colon cancer
cells via targeting to Fra-1.
Novel evidence for curcumin and boswellic acid induced
chemoprevention through regulation of miR-34a and miR-27a in
colorectal cancer.
Role of miR-34a as a suppressor of L1CAM in endometrial
carcinoma.
Evaluation of MicroRNA Expression Pattern of Gastric
Adenocarcinoma
Associated
with
Socioeconomic,
Environmental and Lifestyle Factors in Northwestern Hungary.
MicroRNA-34a targets notch1 and inhibits cell proliferation in
glioblastoma multiforme.
MicroRNA-34a induces apoptosis in the human glioma cell line,
A172, through enhanced ROS production and NOX2 expression.
Dysregulation of microRNA-34a expression in head and neck
squamous cell carcinoma promotes tumor growth and tumor
angiogenesis.
Methylation-associated silencing of microRNA-34b in
hepatocellular carcinoma cancer.
Development of a lung cancer therapeutic based on the tumor
suppressor microRNA-34.
Overexpression of the miR-34 family suppresses invasive growth of
malignant melanoma with the wild-type p53 gene.
A functional screen identifies miR-34a as a candidate
neuroblastoma tumor suppressor gene.
Restoration of p53/miR-34a regulatory axis decreases survival
advantage and ensures Bax-dependent apoptosis of non-small
cell lung carcinoma cells.
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Table 2

Cancer

SNP/miRNA

hsa-mir-34a

hsa-mir-375

List of miRNAs matched with the mirCancer database.
Profile

Osteosarcoma

Down

Ovarian cancer

Down

Pancreatic cancer

Down

Papillary thyroid carcinoma

Up

Prostate cancer

Down

Prostate cancer

Down

Rectal cancer

Up

Renal cell carcinoma

Down

Retinoblastoma

Down

Squamous carcinoma

Up

Uveal melanoma

Down

Cervical squamous cell carcinoma

Down

Colorectal cancer

Down

Esophageal cancer

Down

Esophageal squamous cell carcinoma

Down

Gastric cancer

Down

Glioma

Down

Head and neck squamous cell carcinoma Down
Hepatocellular carcinoma

Down

Laryngeal squamous cell carcinoma

Down

Nasopharyngeal carcinoma

Down

Non-small cell lung cancer

Down

Oral cancer

Down

Oral carcinoma

Down

191
(Continued)

PubMed
Tumor necrosis factor-related apoptosis inducing ligand induces
cytotoxicity specific to osteosarcoma by microRNA response
elements.
Frequent downregulation of miR-34 family in human ovarian
cancers.
MicroRNA miR-34 inhibits human pancreatic cancer tumorinitiating cells.
MiR-34a targets GAS1 to promote cell proliferation and inhibit
apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad
pathway.
MicroRNA-34a modulates c-Myc transcriptional complexes to
suppress malignancy in human prostate cancer cells.
The microRNA miR-34a inhibits prostate cancer stem cells and
metastasis by directly repressing CD44.
The quantitative analysis by stem-loop real-time PCR revealed
the microRNA-34a, microRNA-155 and microRNA-200c
overexpression in human colorectal cancer.
MicroRNA-34a suppresses malignant transformation by targeting
c-Myc transcriptional complexes in human renal cell carcinoma.
Differential microRNA-34a expression and tumor suppressor
function in retinoblastoma cells.
Unique MicroRNA Expression Profiles in Cervical Cancer.
MicroRNA-34a inhibits uveal melanoma cell proliferation and
migration throughDownregulation of c-Met.
miR-375 is down-regulated in squamous cervical cancer and
inhibits cell migration and invasion via targeting transcription
factor SP1.
Expression levels of microRNA-375 in colorectal carcinoma.
Epigenetic silencing of microRNA-375 regulates PDK1 expression
in esophageal cancer.
Cell-specific detection of miR-375 Downregulation for predicting
the prognosis of esophageal squamous cell carcinoma by miRNA
in situ hybridization.
Snail-regulated MiR-375 inhibits migration and invasion of gastric
cancer cells by targeting JAK2.
Correlation of microRNA-375 Downregulation with unfavorable
clinical outcome of patients with glioma.
Comprehensive MicroRNA profiling for head and neck squamous
cell carcinomas.
miR-375 inhibits autophagy and reduces viability of hepatocellular
carcinoma cells under hypoxic conditions.
miR-375 Suppresses IGF1R Expression and Contributes to
Inhibition of Cell Progression in Laryngeal Squamous Cell
Carcinoma.
Significance of dysregulated metadherin and microRNA-375 in
head and neck cancer.
Decreased expression of microRNA-375 in nonsmall cell lung
cancer and its clinical significance.
Anti-Cancer Drugs Reactivate Tumor Suppressor miR-375
Expression in Tongue Cancer Cells.
Dysregulation of miR-31 and miR-375 expression is associated
with clinical outcomes in oral carcinoma.
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Table 2
SNP/miRNA

List of miRNAs matched with the mirCancer database.

Cancer
Pancreatic cancer

Profile
Down

Pancreatic carcinoma

Down

Pancreatic ductal adenocarcinoma

Down

Pancreatic ductal adenocarcinoma

Down

Squamous carcinoma

Down

Osteosarcoma

Down

Breast cancer

Up

Hepatocellular carcinoma

Up

Laryngeal carcinoma

Up

Breast cancer

Down

Gastric cancer

Up

Hepatocellular carcinoma

Up

Colon cancer

Down

Gastric cancer

Down

Glioblastoma

Down

Hepatocellular carcinoma

Down

Non-small cell lung cancer

Down

Oral squamous cell carcinoma

Down

Osteosarcoma

Down

Ovarian cancer

Up

Colorectal cancer

Down

Gastric cancer

Down

Hepatocellular carcinoma

Down

Non-small cell lung cancer

Down

Colon cancer

Up

hsa-mir-375

hsa-mir-382

hsa-mir-423

hsa-mir-423-3p

hsa-mir-425

hsa-mir-501

hsa-mir-503

hsa-mir-625

hsa-mir-675

(Continued)

PubMed
Expression levels of microRNA-375 in pancreatic cancer.
MicroRNA-375 targets PDK1 in pancreatic carcinoma and
suppresses cell growth through the Akt signaling pathway.
Circulating MicroRNAs in Serum of Human K-ras Oncogene
Transgenic Rats With Pancreatic Ductal Adenocarcinomas.
Knockdown of microRNA-21 inhibits proliferation and increases
cell death by targeting programmed cell death 4 (PDCD4) in
pancreatic ductal adenocarcinoma.
Tumor suppressive microRNA-375 regulates lactate dehydrogenase
B in maxillary sinus squamous cell carcinoma.
miR-382 inhibits tumor growth and enhance chemosensitivity in
osteosarcoma.
Genetic analysis and preliminary function study of miR-423 in
breast cancer.
MicroRNA-423 promotes cell growth and regulates G(1)/S
transition by targeting p21Cip1/Waf1 in hepatocellular
carcinoma.
microRNA-423-3p promotes tumor progression via modulation of
AdipoR2 in laryngeal carcinoma.
Estrogen mediated-activation of miR-191/425 cluster modulates
tumorigenicity of breast cancer cells depending on estrogen
receptor status.
NF-kappaB-dependent MicroRNA-425Upregulation promotes
gastric cancer cell growth by targeting PTEN upon IL-1?
induction.
MicroRNA-501 promotes HBV replication by targeting HBXIP.
MiR-424/503-Mediated RictorUpregulation Promotes Tumor
Progression.
microRNA-503 inhibits gastric cancer cell growth and epithelialto-mesenchymal transition.
MicroRNA-503 acts as a tumor suppressor in glioblastoma for
multiple antitumor effects by targeting IGF-1R.
MicroRNA-503 inhibits the G1/S transition by downregulating
cyclin D3 and E2F3 in hepatocellular carcinoma.
Epigenetic silencing of MicroRNA-503 regulates FANCA
expression in non-small cell lung cancer cell.
Genomewide Study of Salivary MicroRNAs for Detection of Oral
Cancer.
MicroRNA-503 acts as a tumor suppressor in osteosarcoma by
targeting L1CAM.
MicroRNAs overexpressed in ovarian ALDH1-positive cells are
associated with chemoresistance.
Decreased expression of microRNA-625 is associated with tumor
metastasis and poor prognosis in patients with colorectal cancer.
Down-regulated miR-625 suppresses invasion and metastasis of
gastric cancer by targeting ILK.
miR-625 suppresses tumour migration and invasion by targeting
IGF2BP1 in hepatocellular carcinoma.
Low levels of cell-free circulating miR-361-3p and miR-625* as
blood-based markers for discriminating malignant from benign
lung tumors.
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in
human colorectal cancer.
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Table 2

List of miRNAs matched with the mirCancer database.
Cancer

SNP/miRNA

Profile

hsa-mir-877

hsa-mir-92b

hsa-mir-940

(Continued)
PubMed

Glioma

Up

Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by
Deriving miR-675.

Hepatocellular carcinoma

Down

Downregulation of LncRNAH19 and MiR-675 promotes migration
and invasion of human hepatocellular carcinoma cells through
AKT/GSK-3/Cdc25A signaling pathway.

Breast cancer

Down

MicroRNA-874 inhibits cell proliferation and induces apoptosis in
human breast cancer by targeting CDK9.

Gastric cancer

Down

miR-874 functions as a tumor suppressor by inhibiting
angiogenesis through STAT3/VEGF-A pathway in gastric
cancer.

Head and neck squamous cell carcinoma Down

Tumour-suppressive microRNA-874 contributes to cell
proliferation through targeting of histone deacetylase 1 in
head and neck squamous cell carcinoma.

Oral squamous cell carcinoma

Down

Genomewide Study of Salivary MicroRNAs for Detection of Oral
Cancer.

Glioblastoma

Up

The miR-92b functions as a potential oncogene by targeting on
Smad3 in glioblastomas.

Glioma

Up

MiR-92b inhibitor promoted glioma cell apoptosis via targeting
DKK3 and blocking the Wnt/beta-catenin signaling pathway.

Non-small cell lung cancer

Up

Inhibition of miR-92b suppresses nonsmall cell lung cancer cells
growth and motility by targeting RECK.

Prostate cancer

Down

MicroRNA-940 suppresses prostate cancer migration and invasion
by regulating MIEN1.

Down

MiR-96-5p influences cellular growth and is associated with poor
survival in colorectal cancer patients.

Breast cancer

Down

Breast cancer-specific TRAIL expression mediated by miRNA
response elements of let-7 and miR-122.

Bronchioloalveolar carcinoma

Down

let-7 microRNA expression is reduced in bronchioloalveolar
carcinoma, a non-invasive carcinoma, and is not correlated with
prognosis.

Colon cancer

Down

let-7 microRNA functions as a potential growth suppressor in
human colon cancer cells.

Esophageal squamous cell carcinoma

Down

MicroRNA-98 and microRNA-214 post-transcriptionally regulate
enhancer of zeste homolog 2 and inhibit migration and invasion
in human esophageal squamous cell carcinoma.

Gastric cancer

Up

MicroRNA profiling of human gastric cancer.

Glioma

Down

Overexpression of RKIP inhibits cell invasion in glioma cell lines
throughUpregulation of miR-98.

Hepatocellular carcinoma

Down MicroRNAs in Hepatobiliary and Pancreatic Cancers.

Lung cancer

Down

Let-7a elevates p21(WAF1) levels by targeting of NIRF and
suppresses the growth of A549 lung cancer cells.

Malignant melanoma

Down

miR-98 suppresses melanoma metastasis through a negative
feedback loop with its target gene IL-6.

Nasopharyngeal carcinoma

Down

MicroRNA let-7 suppresses nasopharyngeal carcinoma cells
proliferation through downregulating c-Myc expression.

Neuroblastoma

Down

LIN28B induces neuroblastoma and enhances MYCN levels via let7 suppression.

Ovarian cancer

Down

EZH2-specific microRNA-98 inhibits human ovarian cancer stem
cell proliferation via regulating the pRb-E2F pathway.

Pancreatic ductal adenocarcinoma

Down

let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits
in vitro cell proliferation but fails to alter tumor progression.

hsa-mir-675

hsa-mir-874

193

hsa-mir-96-5p Colorectal cancer

hsa-mir-98

194

networks by integrating many other types of genomic
and epigenomic data sets. Although we used ovarian
cancer data to demonstrate the usage of our method,
our approach can be applied to identify genetic
neighborhood in any disease with similar genomic data
available. Such an integrative network constructed from
integrating diverse data layers will be more informative
for understanding the propagation of perturbation
signals and the underlying mechanisms of complex
diseases.
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